JPS5138411A - - Google Patents

Info

Publication number
JPS5138411A
JPS5138411A JP50093231A JP9323175A JPS5138411A JP S5138411 A JPS5138411 A JP S5138411A JP 50093231 A JP50093231 A JP 50093231A JP 9323175 A JP9323175 A JP 9323175A JP S5138411 A JPS5138411 A JP S5138411A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50093231A
Other languages
Japanese (ja)
Inventor
Jagannasu Rajadoyaakush Bizaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nelson Research and Development Co
Original Assignee
Nelson Research and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co
Publication of JPS5138411A publication Critical patent/JPS5138411A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP50093231A 1974-08-01 1975-08-01 Pending JPS5138411A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US493751A US3920824A (en) 1974-08-01 1974-08-01 Stable ophthalmic formulation

Publications (1)

Publication Number Publication Date
JPS5138411A true JPS5138411A (enExample) 1976-03-31

Family

ID=23961553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50093231A Pending JPS5138411A (enExample) 1974-08-01 1975-08-01

Country Status (5)

Country Link
US (1) US3920824A (enExample)
JP (1) JPS5138411A (enExample)
DE (1) DE2532017C2 (enExample)
FR (1) FR2280373A1 (enExample)
GB (1) GB1513916A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598423A (en) * 1979-01-22 1980-07-26 Aichi Electric Works Changeover switch

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356885A (en) * 1991-04-24 1994-10-18 American Cyanamid Company Substituted oxotremorine derivatives and pharmaceutical use thereof
US5550257A (en) * 1991-04-24 1996-08-27 American Cyanamid Company Substituted oxotremorine derivatives
US5521210A (en) * 1993-04-13 1996-05-28 Allergan, Inc. Ophthalmic use of muscarinic agonists having increased duration of activity
AU2003218059A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
US3856790A (en) * 1970-01-06 1974-12-24 American Home Prod Cyclic amides of 1,4-diaminobut-2-yne
US3824313A (en) * 1973-03-16 1974-07-16 Nelson Res & Dev Topical opthalmic composition and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598423A (en) * 1979-01-22 1980-07-26 Aichi Electric Works Changeover switch

Also Published As

Publication number Publication date
FR2280373A1 (fr) 1976-02-27
DE2532017A1 (de) 1976-02-19
FR2280373B1 (enExample) 1979-09-14
US3920824A (en) 1975-11-18
DE2532017C2 (de) 1984-08-02
GB1513916A (en) 1978-06-14

Similar Documents

Publication Publication Date Title
FR2258876B1 (enExample)
FR2256434B1 (enExample)
DK141276C (enExample)
FR2280373B1 (enExample)
FI381074A7 (enExample)
DK381075A (enExample)
AU6717074A (enExample)
AU7463174A (enExample)
FI750727A7 (enExample)
AU479523A (enExample)
BG19616A1 (enExample)
BG20431A1 (enExample)
BG20451A1 (enExample)
BG20242A1 (enExample)
BG20240A1 (enExample)
BG20159A1 (enExample)
BG19990A1 (enExample)
BG19892A1 (enExample)
BG19886A1 (enExample)
BG19773A1 (enExample)
BG19770A1 (enExample)
BG19766A1 (enExample)
BG19726A1 (enExample)
AU7504272A (enExample)
CH583619A5 (enExample)